The Cannabinoid Patent Gold Rush: What Pharma IP Veterans Know That Cannabis Companies Don’t
Cannabinoid IP is the most misunderstoodand most valuableasset class in this new pharma era.
Heres the hook: many cannabis companies are still competing like theyre building a consumer brand. Pharma veterans know theyre really building a patent portfol…
